Hepatitis C Virus, Oxidative Stress and Steatosis: Current Status and Perspectives

被引:28
作者
Gonzalez-Gallego, J. [1 ]
Garcia-Mediavilla, M. V.
Sanchez-Campos, S.
机构
[1] Univ Leon, Inst Biomed IBIOMED, E-24071 Leon, Spain
关键词
Calcium; core protein; hepatitis C virus; insulin resistance; NS5A protein; oxidative stress; replication; steatosis; NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; ENDOPLASMIC-RETICULUM STRESS; TRIGLYCERIDE TRANSFER PROTEIN; CORE PROTEIN; INSULIN-RESISTANCE; DNA-DAMAGE; REACTIVE OXYGEN; GENE-EXPRESSION; CHRONIC HCV;
D O I
10.2174/156652411795976592
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Reactive oxygen and nitrogen species (ROS/RNS), whether produced endogenously as a consequence of normal cell functions or derived from external sources, pose a constant threat to cells living in an aerobic environment. When the production of ROS/RNS overrides the antioxidant capability of the target cells, oxidative damage may occur as a consequence of the interaction with DNA, protein, and lipids. Hepatitis C virus (HCV) is a major cause of viral hepatitis. Although the molecular mechanisms of HCV pathogenesis remain unclear, oxidative stress is emerging as a key step and a major initiator in the development and the progression of liver damage, and the evaluation of oxidative stress may be useful for a better understanding of the pathogenesis of hepatitis C. Liver steatosis is one of the most important histopathological features in patients with chronic hepatitis C. Both viral and host factors contribute to the development of steatosis, and putative defects caused by ROS/RNS may be involved through abnormalities in lipid metabolism. This review is aimed to offer an updated overview of the relationship between oxidative stress and HCV infection, focusing on the significance of ROS/RNS in the pathogenesis of liver disease. The potential role played by oxidative stress in the pathogenic mechanisms of HCV-related steatosis is also discussed.
引用
收藏
页码:373 / 390
页数:18
相关论文
共 164 条
[1]   Hepatitis C virus-core and non structural proteins lead to different effects on cellular antioxidant defenses [J].
Abdalla, MY ;
Ahmad, IM ;
Spitz, DR ;
Schmidt, WN ;
Britigan, BE .
JOURNAL OF MEDICAL VIROLOGY, 2005, 76 (04) :489-497
[2]   An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation [J].
Abid, K ;
Pazienza, V ;
de Gottardi, A ;
Rubbia-Brandt, L ;
Conne, B ;
Pugnale, P ;
Rossi, C ;
Mangia, A ;
Negro, F .
JOURNAL OF HEPATOLOGY, 2005, 42 (05) :744-751
[3]   Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C [J].
Adinolfi, LE ;
Ingrosso, D ;
Cesaro, G ;
Cimmino, A ;
D'Antò, M ;
Capasso, R ;
Zappia, V ;
Ruggiero, G .
HEPATOLOGY, 2005, 41 (05) :995-1003
[4]   EVIDENCE FOR A LINK BETWEEN HEPATITIS-C VIRUS-INFECTION AND DIABETES-MELLITUS IN A CIRRHOTIC POPULATION [J].
ALLISON, MED ;
WREGHITT, T ;
PALMER, CR ;
ALEXANDER, GJM .
JOURNAL OF HEPATOLOGY, 1994, 21 (06) :1135-1139
[5]  
Amaro MJ, 1997, J MED VIROL, V51, P326, DOI 10.1002/(SICI)1096-9071(199704)51:4<326::AID-JMV11>3.0.CO
[6]  
2-G
[7]   Hepatitis C Virus Controls Interferon Production through PKR Activation [J].
Arnaud, Noella ;
Dabo, Stephanie ;
Maillard, Patrick ;
Budkowska, Agata ;
Kalliampakou, Katerina I. ;
Mavromara, Penelope ;
Garcin, Dominique ;
Hugon, Jacques ;
Gatignol, Anne ;
Akazawa, Daisuke ;
Wakita, Takaji ;
Meurs, Eliane F. .
PLOS ONE, 2010, 5 (05)
[8]   NADPH oxidase: An update [J].
Babior, BM .
BLOOD, 1999, 93 (05) :1464-1476
[9]   Infliximab reverses steatosis and improves insulin signal transduction in liver of rats fed a high-fat diet [J].
Barbuio, Raquel ;
Milanski, Marciane ;
Bertolo, Manoel B. ;
Saad, Mario J. ;
Velloso, Licio A. .
JOURNAL OF ENDOCRINOLOGY, 2007, 194 (03) :539-550
[10]   Effects of iron loading on pathogenicity in hepatitis C virus-infected chimpanzees [J].
Bassett, SE ;
Di Bisceglie, AM ;
Bacon, BR ;
Sharp, RM ;
Govindarajan, S ;
Hubbard, GB ;
Brasky, KM ;
Lanford, RE .
HEPATOLOGY, 1999, 29 (06) :1884-1892